2. 您的位置
3. 首页
4. 会议论文
5. Prevalence of Lung Cancer Among Women Never Smokers at Adam Malik General Hospital, Medan, Indonesia

Prevalence of Lung Cancer Among Women Never Smokers at Adam Malik General Hospital, Medan, Indonesia

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：spls108

【摘 要】

：

Lung cancer in never smokers patients is on the seventh rank,the most common cause of cancer-related mortality,then it is followed by cancers of the cervix,pancreas,and prostate.

【作 者】

：

Noni Soeroso 

【机 构】

：

Department of Pulmonology and Respiratory Medicine University of Sumatera Utara-Adam Malik General H

【出 处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年7期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Lung cancer in never smokers patients is on the seventh rank,the most common cause of cancer-related mortality,then it is followed by cancers of the cervix,pancreas,and prostate.

其他文献

Effect of Methylene Blue-mediated Photodynamic Therapy for Treatment of Basal Cell Carcinoma

Photodynamic therapy (PDT) is regarded as a treatment option for basal cell carcinoma (BCC).The aim of this study is to investigate the efficacy of methylene blue (MB)-based PDT in patients suffering

会议

OncoCiDia: An Original Research on Targeted Broad-spectrum Chemoradioablation of Solid Malignancies

In our original attempts to reshape anticancer arsenals from traumatic surgery,through minimally invasive interventions into noninvasive targeted strategy,we have developed a broad-spectrum chemoradio

会议

A Novel Inducible Lentiviral Vector for Cell Therapy

As growing promise in engineered immune cells for cancer therapy,for example,Chimeric Antigen Receptors T cells (CAR-T) can recognize and eliminate tumor cells expressing specific antigens,optimal man

会议

Targeted Therapy for Metastatic Gastric Cancer

Gastric cancer is the third leading cause of cancer related death worldwide,and some of the highest mortality rates are in East Asia.Targeted cancer therapies provide new hope to patients with gastric

会议

Health-related Quality of Life in a Randomised Phase Ⅲ Studies of the Combination of Dabrafenib and

Melanoma is one of the most aggressive malignant diseases in human,and the best treatment outcome could be achieved when the diseases is diagnosed at the earlier stages.

会议

Endoscopic Tracheo-bronchial Cryosurgery in Cancer Patients

In recent years,major advances have been made in interventional.Notable techniques have been developed and actually cryosurgery has positioned in an important place in solution of lung and trachea-bro

会议

Comparision of the Expression of 17-beta-hydroxysteroid Dehydrogenases Type 1 and Type 2 in Primary

Non-small cell lung cancer (NSCLC) is the predominant type of lung cancer,the most common malignancy in the world.Although lung carcinogenesis is an extensively studied disorder,it still requires clar

会议

TOPK Promotes Lung Cancer Resistance to EGFR Tyrosine Kinase Inhibitors by Phosphorylating and Activ

Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have shown promising clinical efficacy in non-squamous non-small cell lung cancer (NSCLC);however,resistance is

会议

The Evolution of Treatment of Non Small Cell Lung Cancer from Empiric Treatment to Personalized Trea

Lung Cancer is the most frequent cancer worldwide with more than 1,3 M new case each year.The years 2000 saw two major changes in lung cancer,the predominance of adenocarcinoma and a personalized trea

会议

Combination of Angiogenesis Inhibitor (Endostar) and EGFR-TKIs in Patients with Advanced Non-small C

The aim of this study was to evaluate the clinical activity of another angiogenesis inhibitor Endostar (rh-endostatin) in combination with continued EGFR-TKIs (including erlotinib,gefitinib and icotin

会议